Monthly Archives: August 2011

August 18 2011 Utility of a simplified ultrasound assessment to assess interstitial pulmonary fibrosis in connective tissue disorders – Preliminary results.

Posted on August 18, 2011 by IPF Today

IntroductionInterstitial pulmonary fibrosis (IPF) is a frequent manifestation in patients with connective tissue disorders (CTD). Recently the ultrasound (US) criterion validity for its assessment has been proposed, however the US scoring systems adopted include the study of several lung intercostal … Continue reading →

Posted in IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , | 1 Comment

August 15 2011 Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells

Posted on August 18, 2011 by IPF Today

(TRANSLATION) De Telegraaf (The Netherlands) – Dutch Newspaper Monday August 15 2011, 12:24 Creating stem cells from humans a step closer LONDON – Researchers from the Erasmus University in Rotterdam have discovered how a protein causes embryonic stem cell can … Continue reading →

Posted in IPF, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , | Leave a comment

August 5 2011 InterMune Loss Rise, Costs Flare Up

Posted on August 6, 2011 by IPF Today

InterMune Inc. (NASDAQ:ITMN) posted second-quarter adjusted loss per share of 68 cents, wider than the Zacks Consensus Estimate of a loss per share of 61 cents and the year-ago loss per share of 44 cents. Steeper operating expenses resulted in … Continue reading →

Posted in Uncategorized | Tagged | Leave a comment

August 4 2011 InterMune Reports Second Quarter 2011 Financial Results and Business Highlights

Posted on August 6, 2011 by IPF Today

BRISBANE, Calif., Aug. 4, 2011 /PRNewswire/ — InterMune, Inc. (NASDAQ:   ITMN) today announced results from operations for the second quarter and six months ended June 30, 2011.  InterMune also highlighted its recent business and clinical development activities, as well as … Continue reading →

Posted in Uncategorized | Leave a comment